Vascular endothelial growth factor C936T polymorphism in cancer patients with thrombosis

被引:11
作者
Eroglu, Aydan [1 ]
Gulec, Sukru
Akar, Nejat
机构
[1] Numune State Hosp, Dept Gen Surg & Surg Oncol, Konya, Turkey
[2] Ankara Univ, Inst Biotechnol, TR-06100 Ankara, Turkey
[3] Ankara Univ, Sch Med, Dept Pediat Mol Genet, TR-06100 Ankara, Turkey
关键词
D O I
10.1002/ajh.20719
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:174 / 174
页数:1
相关论文
共 5 条
[1]   Novel polymorphisms in the promoter and 5′ UTR regions of the human vascular endothelial growth factor gene [J].
Brogan, IJ ;
Khan, N ;
Isaac, K ;
Hutchinson, JA ;
Pravica, V ;
Hutchinson, IV .
HUMAN IMMUNOLOGY, 1999, 60 (12) :1245-1249
[2]   Factor V Leiden and PT G20210A mutations in cancer patients with and without venous thrombosis [J].
Eroglu, A ;
Kurtman, C ;
Ulu, A ;
Çam, R ;
Akar, N .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (06) :1323-1324
[3]   Genetic risk factors of venous thrombosis [J].
Franco, RF ;
Reitsma, PH .
HUMAN GENETICS, 2001, 109 (04) :369-384
[4]   The role of VEGF in oncology: Effects on hemostasis and thrombosis [J].
Pinedo, HM .
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS, 2003, 33 :11-12
[5]   A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels [J].
Renner, W ;
Kotschan, S ;
Hoffmann, C ;
Obermayer-Pietsch, B ;
Pilger, E .
JOURNAL OF VASCULAR RESEARCH, 2000, 37 (06) :443-448